Daniel W. Armstrong, a professor of chemistry and biochemistry at the University of Texas Arlington in Texas (USA) is to receive the 2014 American Chemical Society Award in Separations Science and Technology. This is the second time this year that the ACS has recognized the work of Armstrong – in August last year he was selected to join the ACS Class of Fellows 2013.
Daniel W. Armstrong, a professor of chemistry and biochemistry at the University of Texas Arlington in Texas (USA) is to receive the 2014 American Chemical Society Award in Separations Science and Technology. This is the second time this year that the ACS has recognized the work of Armstrong — in August last year he was selected to join the ACS Class of Fellows 2013.
The award, sponsored by Waters Corp., recognizes "the development of novel applications with major impacts and/or the practical implementations of modern advancements in the field of separation science and technology." It will be presented to Armstrong on March 17 at the ACS national conference in Dallas, USA.
Armstrong is considered a leader in his field and is considered to be the “father” of pseudo-phase separations — a type of chromatography that lowers costs, volatility, and toxicity while providing higher selectivity than other analytical methods. Furthermore his commercialized innovations are applied across the drug development, environmental analysis, and petrochemical industries.
Armstrong said: “"One of the strengths of our group is we come with new things to explore constantly, which is fun. You want to do things that have an impact and are useful, either adding knowledge, insight or something practical that people can actually use." In his career he has developed more than 30 different chromatography columns — a gas chromatography column that Armstrong developed is now part of the Rosetta mission of the European Space Agency exploring the composition of comets in space.
Furthermore, Armstrong has published more than 550 scientific publications, including 29 book chapters and holds 23 U.S. and international patents. He is also a member of the LCGC Europe and LCGC North America Editorial Advisory Boards.
Ronald L. Elsenbaumer, UT Arlington provost and vice president for academic affairs said: "Throughout his career, Armstrong has worked to increase our understanding of the world around us through development of new instruments and analytical methods." He added: "His international reputation has elevated the College of Science and the University overall, and we are pleased to see this recognition of his contributions."
Related Content:
Read further work by Daniel W. Armstrong Rapid, Efficient Quantification of Water in Solvents and Solvents in Water Using an Ionic Liquid-based GC Column”
For more information from UT Arlington please click here.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.